Given the critical importance of endocytosis detection in ADC research and development, ACROBiosystems has designed an ...

Eli Lilly (NYSE: LLY) is part of this group. On Sept. 16, the drugmaker announced plans to build a $5 billion facility in ...

Salubris Biotherapeutics, Inc. (SalubrisBio), a clinical-stage biotechnology company dedicated to discovering and developing novel complex biologic therapeutics, today announced data from the dose ...

The intriguing startup NextSilicon, which has generated attention in HPC and other advanced computing markets since its ...

ADC usage in breast cancer treatment increased 3.7-fold from 2021 to 2023, with significant reductions in median time to ...

Yale researchers revealed how vitamin B5 fuels mitochondria, offering new insight into brain and metabolic disorders. The human body produces a molecule from vitamin B5 that plays a crucial role in ...

Nearly two dozen antibody drug conjugates (ADCs) have now been approved worldwide and revenues were already well into the ...

Syngene International, a global CRDMO, is adding a GMP bioconjugation suite at its commercial biologics facility [Unit 3] in Bengaluru. With this new capability, Syngene will offer fully integrated, ...

Syngene International plans to add bioconjugation suite for end-to-end ADC development: Our Bureau, Bengaluru Thursday, October 23, 2025, 15:15 Hrs [IST] Syngene International, a ...

Alloy Therapeutics has acquired Spannerwerks LLC, a consultancy that advises biopharmaceutical companies on product development and commercialization.

Discusses Updated Monotherapy Phase I Data for Suzhou and Outlines Next Steps in Clinical Development October 24, 2025 ...